Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTPa-IPV/Hib combination vaccine primary series in South Korean infants
2012-004137-16Phase 3
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of acthib + dpt-ipv, diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine, haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b disease (Hib), sponsored by GSK.
02
Drugs
acthib + dpt-ipvdiphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccinehaemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2012-004137-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004137-16.